Studies related to Bilirubin and Picrorhiza kurroa

Picrorhiza Kurroa (Kutaki) Royle Ex Benth As A Hepatoprotective Agent--experimental & Clinical Studies

Effect Decrease
Trial Design Double blind
Trial Length 1-2 Weeks
Number of Subjects 33
Gender Both Genders
Notes for this study:
375mg _picrorhiza kurroa_ thrice daily (daily dose of 8.16-8.64mg picroside I and 16.5-18mg picroside II) for two weeks in patients with acute viral hepatitis noted reductions in bilirubin and liver enzymes associated with treatment which exceeded placebo at days 7 and 14 (day 4 showed a nonsignificant trend).